Sonic Healthcare Ltd · Financials

ASX: SHL · Health Care · Diagnostics & Research

A$21.86
At close 31 Jul 2026

Income Statement, FY16–FY25

Revenue, costs and profitability, exactly as reported in each year's audited accounts. Negative figures shown in (brackets).

10 financial years
Line item FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Revenue
Total Revenue 5.0B 5.1B 5.5B 6.1B 6.8B 8.8B 9.3B 8.2B 9.0B 9.6B
Costs and Expenses
Cost of Revenue (918M) (995M) (1.1B) (1.6B) (1.6B) (1.3B) (1.5B) (1.6B)
Gross Profit 5.0B 5.1B 4.6B 5.1B 5.7B 7.1B 7.7B 6.9B 7.5B 8.1B
Operating Expenses (4.4B) (4.5B) (3.9B) (4.4B) (4.9B) (5.2B) (5.6B) (5.9B) (6.7B) (7.2B)
Operating Income 665M 644M 695M 808M 812M 1.9B 2.2B 1.0B 882M 931M
Other Income/Expenses
Interest Expense (67M) (68M) (78M) (86M) (113M) (93M) (80M) (87M) (151M) (181M)
Profit Before Taxes 598M 576M 617M 722M 699M 1.8B 2.1B 931M 731M 751M
Income Tax (132M) (133M) (132M) (163M) (157M) (481M) (562M) (223M) (187M) (207M)
Net Income 451M 428M 476M 550M 528M 1.3B 1.5B 685M 511M 514M
Per Share Data
Basic EPS 1.1 1.027 1.126 1.225 1.111 2.755 3.055 1.458 1.073 1.07
Diluted EPS 1.093 1.021 1.122 1.221 1.106 2.731 3.025 1.45 1.072 1.067
Shares Outstanding (in millions)
Basic Shares 410M 417M 422M 449M 475M 477M 478M 470M 476M 480M
Diluted Shares 413M 419M 424M 450M 477M 481M 483M 472M 477M 481M

Balance Sheet, FY16–FY25

Assets, liabilities and shareholders' equity at each financial year end. Negative figures shown in (brackets).

10 financial years
Line item FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Current Assets
Cash & Cash Equivalents 290M 438M 313M 737M 1.2B 900M 780M 798M 645M 674M
Short-term Investments
Accounts Receivable 704M 717M 747M 828M 987M 1.1B 1.2B 1.0B 1.4B 1.5B
Inventories 89M 96M 107M 120M 163M 224M 216M 199M 209M 227M
Total Current Assets 1.1B 1.3B 1.2B 1.8B 2.5B 2.3B 2.3B 2.1B 2.4B 2.6B
Non-Current Assets
Property, Plant & Equipment (Net) 958M 1.1B 1.2B 1.3B 1.2B 1.3B 1.3B 1.5B 1.7B 1.8B
Investments 56M 38M 40M 88M 92M 108M 145M 176M 198M 231M
Intangible Assets 5.2B 5.4B 5.7B 6.8B 7.0B 6.7B 7.4B 7.8B 9.1B 9.8B
Goodwill
Total Non-Current Assets 6.2B 6.6B 7.0B 8.2B 9.7B 9.5B 10.2B 10.9B 12.5B 13.4B
Total Assets 7.4B 7.9B 8.2B 10.0B 12.1B 11.8B 12.6B 13.0B 14.8B 16.1B
Current Liabilities
Short-term Debt & Overdrafts 476M 821M 4M 826M 364M 229M 297M 81M
Trade Payables 494M 510M 519M 627M 984M 1.0B 1.0B 960M 1.2B 1.3B
Total Current Liabilities 1.2B 1.6B 868M 1.8B 2.1B 2.2B 2.1B 1.9B 2.3B 2.2B
Non-Current Liabilities
Long-term Debt 2.1B 2.1B 2.8B 2.2B 2.9B 1.6B 1.6B 1.7B 2.7B 3.4B
Total Non-Current Liabilities 2.4B 2.3B 3.1B 2.6B 4.4B 3.0B 3.0B 3.2B 4.4B 5.4B
Total Liabilities 3.6B 4.0B 3.9B 4.5B 6.5B 5.3B 5.1B 5.1B 6.8B 7.6B
Shareholders' Equity
Share Capital 2.8B 2.9B 3.0B 4.0B 4.0B 4.1B 3.9B 3.8B 4.1B 4.1B
Retained Earnings 872M 997M 1.1B 1.3B 1.4B 2.3B 3.4B 3.6B 3.6B 3.5B
Total Shareholders' Equity 3.7B 3.9B 4.3B 5.5B 5.7B 6.5B 7.4B 7.9B 8.1B 8.5B
Total Liabilities & Equity 7.4B 7.9B 8.2B 10.0B 12.1B 11.8B 12.6B 13.0B 14.8B 16.1B

Cash Flow, FY16–FY25

Cash generated and spent across operating, investing and financing activities. Negative figures shown in (brackets).

10 financial years
Line item FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Operating Activities
Net Income
Cash from Operating Activities 708M 736M 768M 847M 1.4B 2.0B 2.2B 1.5B 1.1B 1.3B
Investing Activities
Investments in PPE (322M) (337M) (226M) (282M) (235M) (274M) (287M) (389M) (471M) (336M)
Cash from Investing Activities (786M) (673M) (464M) (1.1B) (335M) (387M) (989M) (580M) (1.8B) (578M)
Financing Activities
Debt Repayments (632M) 328M (952M) (1.2B) (1.3B) (1.4B) (576M) (290M) (745M) (1.8B)
Share Repurchases (303M) (131M) (10M)
Dividends Paid (219M) (281M) (240M) (374M) (412M) (426M) (471M) (491M) (559M) (567M)
Cash from Financing Activities 120M 84M (428M) 675M (532M) (2.0B) (1.4B) (873M) 581M (690M)
Cash Position
Cash at Beginning of Period 249M 290M 438M 313M 737M 1.2B 900M 780M 798M 645M
Cash at End of Period 290M 438M 313M 737M 1.2B 900M 780M 798M 645M 674M
Free Cash Flow
Free Cash Flow (Reported) 385M 399M 542M 566M 1.1B 1.8B 1.9B 1.1B 601M 961M
Free Cash Flow (Calculated) 385M 399M 542M 566M 1.1B 1.8B 1.9B 1.1B 601M 961M

Data is general information only, not financial advice. Figures are as reported in company filings (some ASX companies report in USD); share prices are AUD.